Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection

Heart

Volumn 85, Issue 1, 2001, Pages 61-65

  Ravn, H B ^a   Hjortdal, V E ^a   Stenbog, E V ^a   Emmertsen, K ^a   Kromann, O ^a   Pedersen, J ^a   Sorensen, K E ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Coagulation; Fontan procedure; Platelets; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANTICOAGULANT AGENT; ANTITHROMBIN III; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; COLLAGEN; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADOLESCENT; ADULT; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CHILD; CLINICAL ARTICLE; FEMALE; FONTAN PROCEDURE; GLENN ANASTOMOSIS; HEART SINGLE VENTRICLE; HUMAN; LUNG ARTERIOVENOUS SHUNT; MALE; PRIORITY JOURNAL; PROTEIN SECRETION; SURGICAL TECHNIQUE; THROMBOCYTE AGGREGATION; THROMBOEMBOLISM; TOTAL CAVOPULMONARY CONNECTION;

EID: 0034763053     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.85.1.61     Document Type: Article

References (33)

1. Surgical repair of tricuspid atresia
2. Protein losing enteropathy after Fortran operation
3. Long-term results after the Fontan operation for tricuspid atresia
4. Liver fibrosis (cardiac cirrhosis) five years after modified Fortran operation for tricuspid atresia
5. Protein losing enteropathy and after the Fontan operation
6. The Fontan circulation: What have we learned? What to expect?
7. Thromboembolism after the Fontan procedure and its modifications
8. Factors associated with stroke following the Fontan procedure
9. Thromboembolic complications after Fontan operations
10. Arrhythmias and thromboembolic complications after the extracardiac Fontan operation
11. Thromboembolic complications after Fontan procedures - The role of prophylactic anticoagulation
12. Formation of thrombus and thromboembolism after the bidirectional Glenn anastomosis, total cavopulmonary connection and the Fontan procedure
13. Intracardiac thrombus after the Fontan procedure
14. Coagulation factor abnormalities as possible thrombotic risk factors after the Fontan operation
15. Specific sequelae after Fontan operation at mid- and long-term follow-up
16. Coagulation factor abnormalities after the Fontan procedure and its modifications
17. Total extracardiac right heart bypass
18. Superior vena cava-pulmonary artery anastomosis
19. Total cavopulmonary connection: A logical alternative to atriopulmonary connection for complex Fontan operations
20. Aggregation of blood platelets by adenosine diphosphate and its reversal
21. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: Insights from studies of vascular biology
22. Operative venous dilation and its relation to postoperative deep venous thrombosis
23. Thrombosis in the young: Epidemiology and risk factors. A focus on venous thrombosis
24. Mechanisms initiating platelet thrombus formation
25. Congenital and acquired hypercoagulable states
26. Practical dosing considerations with warfarin and optimal therapeutic range
27. Thrombosis of the pulmonary artery stump after distal ligation
28. Systemic thromboembolism leading to myocardial infarction and stroke after fenestrated total cavopulmonary connection
29. Fenestrated Fontan procedure: Evolution of technique and occurrence of paradoxical embolism
30. Enhanced thrombin regulation during warfarin therapy in children compared to adults
31. Collaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft or arterial patency by antiplatelet therapy
32. Collaborative overview of randomised trials of antiplatelet therapy - III: Reduction of venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients
33. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement